209958-57-6Relevant articles and documents
CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF
-
Paragraph 0866, (2018/04/17)
Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.
NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
-
Page/Page column 35, (2009/10/01)
The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.
Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2′-(methylsulfonyl)-[1,1′-b iphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa
Pinto,Orwat,Wang,Fevig,Quan,Amparo,Cacciola,Rossi,Alexander,Smallwood,Luettgen,Liang,Aungst,Wright,Knabb,Wong,Wexler,Lam
, p. 566 - 578 (2007/10/03)
Factor Xa (fXa) plays a critical role in the coagulation cascade, serving as the point of convergence of the intrinsic and extrinsic pathways. Together with nonenzymatic cofactor Va and Ca2+ on the phospholipid surface of platelets or endotheli